The concentration of anthelmintic reaching the target worms in the host can vary between animals even when administered doses are tailored to individual liveweight at the manufacturer’s recommended rate. Factors contributing to variation in drug concentration include weather, breed of animal, formulation and the route by which drugs are administered. The implications of this variability for the development of anthelmintic resistance was investigated using Monte-Carlo simulation. A model framework was established where 100 animals each received a single drug treatment with the dose of drug reaching the target worms being sampled at random from a distribution of doses with mean m and standard deviation s. For each animal the dose of drug was used in conjunction with pre-determined dose-response relationships, representing single and poly-genetic inheritance, to calculate efficacy against susceptible and resistant genotypes. These data were then used to calculate the overall change in resistance gene frequency for the worm population as a result of the treatment. Values for m and s were varied to reflect differences in both mean dose and the variability in dose, and for each combination of these 100,000 simulations were run. The mean and standard deviation of the resulting increases in resistance gene frequency were compared to understand the consequences of varying the concentration of drug reaching the target worms on the development of drug resistance.
Leathwick, D. M., & Luo, D. (2017). Managing anthelmintic resistance: variability in the dose of drug reaching the target worms influences selection for resistance? Veterinary Parasitology, 243, 29–35. doi:10.1016/j.vetpar.2017.05.032